Siefert, Alyssa L <br/><br/>
Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy.  [electronic resource] 

 -  Biomaterials  08 2016 
 - 85-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1878-5905 
<br/><br/><label>Standard No.: </label>10.1016/j.biomaterials.2016.03.039  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Bacterial Agents--pharmacology<br/>Antibody Formation--drug effects<br/>Bacterial Vaccines--immunology<br/>Biomimetic Materials--pharmacology<br/>Dendritic Cells--drug effects<br/>Humans<br/>Immunity, Cellular--drug effects<br/>Lipid A--analogs & derivatives<br/>Mice, Inbred C57BL<br/>Nanoparticles--chemistry<br/>Oligodeoxyribonucleotides--pharmacology<br/>Pathogen-Associated Molecular Pattern Molecules--metabolism<br/>Th1 Cells--drug effects<br/>Toll-Like Receptors--metabolism